NIH-funded research NIH-funded research

Developing tools to fight antibiotic-resistant bacteria

Official title: Bioinformatics Tools and Services at NCBI for Combating Antibiotic Resistant Bacteria Research

Funded at Black Canyon Consulting LLC · NIH-11195961 · Data updated 2026-11-12

This study is working on improving online tools that help scientists and doctors find and understand antibiotic-resistant bacteria, so they can better tackle infections that are hard to treat.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBlack Canyon Consulting LLC
NIH-funded
Lab location1 site (Fairfax, United States)
Project startSeptember 28, 2024
Project endSeptember 27, 2025
Funding year2024
Award (this year)$2,500,000
NIH project number75N97023F00098-P00001-0-1
Project IDNIH-11195961 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include patients with infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients with infections that are not caused by antibiotic-resistant bacteria may not receive any benefit from this research.

What this research studies

This research focuses on enhancing bioinformatics tools and services at the National Center for Biotechnology Information (NCBI) to combat antibiotic-resistant bacteria. It aims to improve resources such as the National Database of Resistant Organisms (NDARO) and tools like AMRFinderPlus, which helps identify antibiotic resistance genes in bacterial genomes. By refining these tools, the project seeks to provide better data and resources for researchers and healthcare providers dealing with antibiotic resistance.

Why it matters

Potential benefit: If successful, this research could lead to improved identification and understanding of antibiotic-resistant bacteria, ultimately aiding in better treatment options for patients.

How similar studies have gone: Previous research has shown success in developing bioinformatics tools for tracking antibiotic resistance, indicating that this approach has potential.

Where this research is happening

  • Black Canyon Consulting LLC
    Fairfax, United States
    Active

Researchers

  • Principal investigator: Esser, Haley — Black Canyon Consulting LLC
  • Study coordinator: Esser, Haley

Related research

Other NIH-funded projects on the same topics.

  • Coordination of a gene therapy program focused on adeno-associated viruses.

    This study is all about working together to create new gene therapies that could help people with genetic disorders, so if you're looking for exciting new treatment options, this could be for you!

    NIH research Black Canyon Consulting LLC · Fairfax, United States · NIH-11176667

  • Coordination of a gene therapy program for personalized treatments

    This study is all about bringing together experts to create personalized gene therapies that could help patients with specific genetic conditions, making sure everyone works well together to develop these innovative treatments.

    NIH research Black Canyon Consulting LLC · Fairfax, United States · NIH-10950099

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.